Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is available in the UK without a subscription model. As a prescription-only medicine, it requires a clinical assessment each time you need treatment, but that review does not have to come tied to an automatic monthly charge or a rolling contract. Many regulated online pharmacies, including nume, supply Wegovy on a repeat-order basis where every dispensing is clinically re-reviewed and you decide when to reorder — no auto-renewal, no locked-in billing cycle. The decision you are really making, then, is not whether to accept a subscription but which kind of clinical oversight and payment structure genuinely suits your situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people search for Wegovy without a subscription, they are usually reacting to a specific frustration: being charged automatically, feeling locked in, or worrying they will be billed during months when treatment is paused. Those are legitimate concerns. It helps to separate them from the clinical reality.
Wegovy is a prescription-only medicine, that status is fixed by UK law and does not change based on how a provider structures its billing. What varies between providers is how they handle the commercial side. Some build auto-renewing plans; others, including nume, take a different approach. At nume there is no subscription and no auto-renewal. Each repeat order goes through a fresh clinical review before anything is dispensed. You reorder when you are ready.
The distinction matters because it means the absence of a subscription does not remove clinical involvement, it just removes the automatic charge. A named prescriber, not software, reads your answers before each supply. That is true whether you are on your first pen or your fifth. Understanding how subscription versus repeat-order models differ practically is a useful first step before choosing a provider.
Some providers frame subscription billing as the mechanism that keeps your clinical oversight in place. That framing can make non-subscription routes sound as though they skip the prescriber. They should not, and any legitimate pharmacy will not let them.
Wegovy's dose escalation schedule (starting at 0.25mg and moving through 0.5mg, 1.0mg, 1.7mg and 2.4mg, with the newer 7.2mg maintenance dose now also MHRA-approved) means that a prescriber needs to confirm a dose increase is appropriate before a higher-strength pen is issued. Even at a stable maintenance dose, things change: other medications are added, health conditions evolve, side effects develop that warrant a conversation. The full Wegovy treatment overview covers the escalation schedule and what each stage involves.
The NHS England guidance on weight-management injections is clear that these medicines require ongoing clinical monitoring as part of responsible prescribing. That monitoring is the valuable part. The billing model wrapped around it is secondary.
The practical checklist for anyone wanting Wegovy without a rolling contract is straightforward. First, confirm the pharmacy holds a GPhC registration, you can check any online pharmacy on the GPhC register. A provider that cannot be found there should not be dispensing prescription medicines. Second, confirm there is a real prescriber involved, not just an automated questionnaire with no human review. Third, check what happens at a dose increase: evidence should be required, and a prescriber should make the call.
Pricing is a reasonable consideration too. If you want to compare what is typically included in private Wegovy pricing in the UK, the Wegovy price comparison page sets out what the market looks like and what different headline figures usually do and do not include. One honest note: consultation fees, prescriptions, delivery and aftercare support are often priced separately in services that lead with a low per-pen figure. At nume everything is included in one price, with no hidden additions.
Flexibility also means being able to pause. Treatment can be interrupted for surgery, illness, or personal choice, your prescriber should know, and the prescription process should accommodate that without penalty. If you are thinking about weight-loss options more broadly, it is worth reading about how to lose weight without Wegovy so that Wegovy is a considered choice, not just the first option you encounter.
The route at nume is straightforward. A free consultation is completed online, it covers your medical history, current medicines, BMI, and any relevant conditions. A GPhC-registered independent prescriber reviews it the same day. If clinically suitable, treatment is approved and dispatched the same day for orders placed before midday on a working day, arriving via tracked DPD delivery the next working day in plain, unbranded packaging.
There is no standing order. When you need a repeat, you reorder and the clinical review happens again. Dose increases follow the same process: your prescriber assesses whether the increase is appropriate before the next pen is issued. The pen itself goes in the fridge door when it arrives, the same place it will live until injection day each week.
If you have questions before starting, the frequently asked questions cover the most common concerns about the process. Our clinical team oversees every prescription, and how the service is structured is set out clearly. To check eligibility and speak to a prescriber, the starting point is a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.